AI assistant
RESMED INC — Director's Dealing 2024
Aug 16, 2024
30071_dirs_2024-08-16_44c49e33-fe5d-4d2c-9cb1-67c8c509d369.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2024-08-16
Reporting Person: Farrell Michael J. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-08-15 | ResMed Common Stock | A | 19272 | — | Acquired | 460071 | Direct |
| 2024-08-15 | ResMed Common Stock | A | 4098 | — | Acquired | 464169 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 4090 | Indirect |
Footnotes
F1: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock units vest 1/3
each year on the anniversary of the grant.
F2: Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion of
the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.